Seth Klarman - Baupost Group
Holding/activity history for Theravance Biopharma, Inc. (TBPH)
← All TBPH superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | 1.01 | $7.44–10.42 · VW $8.85i | SEC | |
| 2024 Q2 | 4,200,021 | 1.01 | Reduce 36.31% | 0.61 | $8.13–10.44 · VW $8.94i | $35,616,000 | SEC |
| 2024 Q1 | 6,594,126 | 1.67 | Reduce 11.12% | 0.20 | $8.21–11.71 · VW $9.52i | $59,149,000 | SEC |
| 2023 Q4 | 7,419,226 | 1.82 | $11.24 | $83,392,000 | SEC | ||
| 2023 Q3 | 7,419,226 | 1.25 | $8.63 | $64,028,000 | SEC | ||
| 2023 Q2 | 7,419,226 | 1.39 | Reduce 28.79% | 0.58 | $9.98–12.03 · VW $10.95i | $76,789,000 | SEC |
| 2023 Q1 | 10,419,226 | 2.03 | Reduce 8.76% | 0.19 | $9.25–11.52 · VW $10.59i | $113,049,000 | SEC |
| 2022 Q4 | 11,419,226 | 2.18 | Reduce 14.90% | 0.36 | $9.56–11.83 · VW $10.60i | $128,124,000 | SEC |
| 2022 Q3 | 13,419,226 | 2.44 | $10.14 | $136,071,000 | SEC | ||
| 2022 Q2 | 13,419,226 | 1.87 | Reduce 1.64% | 0.02 | $8.15–10.52 · VW $9.23i | $121,578,000 | SEC |
| 2022 Q1 | 13,643,333 | 1.45 | Reduce 0.12% | <0.01 | $7.71–13.17 · VW $9.89i | $130,430,000 | SEC |
| 2021 Q4 | 13,660,168 | 1.54 | $11.05 | $150,945,000 | SEC | ||
| 2021 Q3 | 13,660,168 | 0.94 | Add 37.84% | 0.26 | $6.10–15.01 · VW $9.12i | $101,085,000 | SEC |
| 2021 Q2 | 9,910,168 | 1.18 | Add 13.45% | 0.14 | $14.46–22.74 · VW $17.75i | $143,896,000 | SEC |
| 2021 Q1 | 8,735,168 | 1.44 | $20.41 | $178,285,000 | SEC | ||
| 2020 Q4 | 8,735,168 | 1.46 | $17.77 | $155,224,000 | SEC | ||
| 2020 Q3 | 8,735,168 | 1.40 | Reduce 6.17% | 0.15 | $14.62–22.82 · VW $18.34i | $129,149,000 | SEC |
| 2020 Q2 | 9,309,168 | 2.45 | $20.99 | $195,399,000 | SEC | ||
| 2020 Q1 | 9,309,168 | 3.19 | $23.11 | $215,135,000 | SEC | ||
| 2019 Q4 | 9,309,168 | 2.80 | $25.89 | $241,014,000 | SEC | ||
| 2019 Q3 | 9,309,168 | 2.26 | $19.48 | $181,343,000 | SEC | ||
| 2019 Q2 | 9,309,168 | 1.49 | $16.33 | $152,019,000 | SEC | ||
| 2019 Q1 | 9,309,168 | 1.89 | $22.67 | $211,039,000 | SEC | ||
| 2018 Q4 | 9,309,168 | 2.16 | $25.59 | $238,222,000 | SEC | ||
| 2018 Q3 | 9,309,168 | 2.39 | $32.67 | $304,131,000 | SEC | ||
| 2018 Q2 | 9,309,168 | 1.90 | $22.68 | $211,132,000 | SEC | ||
| 2018 Q1 | 9,309,168 | 2.20 | $24.25 | $225,747,000 | SEC | ||
| 2017 Q4 | 9,309,168 | 2.59 | $27.89 | $259,633,000 | SEC | ||
| 2017 Q3 | 9,309,168 | 4.05 | Add 0.38% | 0.02 | $23.15–42.61 · VW $32.05i | $318,746,000 | SEC |
| 2017 Q2 | 9,273,991 | 4.42 | $39.84 | $369,476,000 | SEC | ||
| 2017 Q1 | 9,273,991 | 4.14 | $36.82 | $341,468,000 | SEC | ||
| 2016 Q4 | 9,273,991 | 3.96 | Add 26.16% | 0.82 | $24.54–38.92 · VW $29.81i | $295,655,000 | SEC |
| 2016 Q3 | 7,350,991 | 3.93 | $36.24 | $266,400,000 | SEC | ||
| 2016 Q2 | 7,350,991 | 2.33 | Add 13.07% | 0.27 | $15.00–24.76 · VW $21.35i | $166,794,000 | SEC |
| 2016 Q1 | 6,500,991 | 1.81 | Add 1.26% | 0.02 | $12.87–19.00 · VW $16.34i | $122,219,000 | SEC |
| 2015 Q4 | 6,420,028 | 2.07 | $16.39 | $105,224,000 | SEC | ||
| 2015 Q3 | 6,420,028 | 1.26 | $10.99 | $70,556,000 | SEC | ||
| 2015 Q2 | 6,420,028 | 1.59 | Add 0.84% | 0.01 | $12.52–18.92 · VW $14.76i | $83,589,000 | SEC |
| 2015 Q1 | 6,366,577 | 2.03 | Add 5.04% | 0.10 | $14.59–22.00 · VW $18.20i | $110,460,000 | SEC |
| 2014 Q4 | 6,061,228 | 1.94 | $14.92 | $90,434,000 | SEC | ||
| 2014 Q3 | 6,061,228 | 2.60 | $23.05 | $139,711,000 | SEC | ||
| 2014 Q2 | 6,061,228 | 3.51 | Buy | 3.51 | $19.17–35.67 · VW $28.91i IPO/listing quarter |
$193,232,000 | SEC |
Price snapshot:
Current price$16.90
52-week low$10.82
52-week high$21.03